2026. Assessing oxime reactivation efficacy using principal component analysis: Insights from nerve agents inhibited human butyrylcholinesterase: Original scientific  article. ADMET and DMPK. 14, (May 2026). DOI:https://doi.org/10.5599/admet.3361.